BioSpace News Archive

Genetown

Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment

Ratio Therapeutics Inc. today announces the close of its $50M Series B financing, bringing the total raised to date to over $90 million.

January 17, 2024
·
3 min read
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its Bun-Yo-Matic™ Lapidus Clamp System and completion of the first surgical cases in Orange County, California and Seattle, Washington.

January 17, 2024
·
5 min read
BioMidwest

Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons

Vergent Bioscience announced that new results from the Phase 2 clinical program evaluating the company’s investigational agent VGT-309 will be presented at STS 2024, the 60th Annual Meeting of Thoracic Surgeons, taking place January 27-29, 2024, in San Antonio, Texas.

January 17, 2024
·
3 min read
Biotech Beach

Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases

Tr1X, Inc. announced its emergence from stealth with a $75 million Series A financing to bring universal allogeneic regulatory T and CAR-Treg cell therapies to the clinic to treat and potentially cure autoimmune and inflammatory diseases.

January 17, 2024
·
9 min read
Business

Neuvivo Names Dr. James Kovach as Chief Medical Affairs Officer

Neuvivo today announced the appointment of Dr. James Kovach, MD, JD, as its new Chief Medical Affairs Officer.

January 17, 2024
·
3 min read
Pharm Country

Olympus Earns High Marks in Human Rights Campaign Foundation’s Corporate Equality Index

Olympus Corp. of the Americas, a global medical technology company, announced that it received a score of 90 out of 100 on the Human Rights Campaign Foundation’s 2023-24 Corporate Equality Index.

January 17, 2024
·
4 min read
Biotech Bay

Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone

Better Therapeutics Inc. announced the publication of health economic data for its prescription-only digital behavioral treatment for type 2 diabetes, AspyreRx.

January 17, 2024
·
7 min read
BioMidwest

Attune Medical® Announces Support of AF Symposium 2024

Attune Medical®, a pioneer in the field of esophageal temperature management with its ensoETM® device, is providing significant support for the upcoming AF Symposium as part of the company’s corporate mission.

January 17, 2024
·
4 min read
BioMidwest

Smart Meter Builds on Role as Innovator in Cellular Remote Patient Monitoring

Smart Meter, the leading provider of cellular Remote Patient Monitoring solutions, has recently been granted two groundbreaking patents, expanding its position as a healthcare technology innovator.

January 17, 2024
·
3 min read
Business

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the sales and distribution of its products into the Japanese market.

January 17, 2024
·
4 min read